The Know AML website uses a third-party service provided by Google that dynamically translates web content. Translations are machine generated, so may not be an exact or complete translation, and Know AML cannot guarantee the accuracy of translated content. Know AML and its employees will not be liable for any direct, indirect, or consequential damages (even if foreseeable) resulting from use of the Google Translate feature. For further support with Google Translate, visit Google Translate Help. The interviews webpage also uses YouTube, where subtitles and translations are generated automatically by AI; please be advised to exercise caution when precise interpretation is required. For further support with YouTube, visit YouTube Help.
What does remission mean in AML?
Charles Craddock
March 16, 2026
For AML World Awareness Day 2026, Know AML was pleased to speak with Know AML Ambassadors Erik Aerts, a specialist hematology nurse based in Switzerland, and Charles Craddock, an acute myeloid leukemia (AML) physician based in the United Kingdom. We asked, What does remission mean in AML?
Erik and Charles explain that when someone with AML is in remission, it means that doctors cannot see any signs of leukemia in the blood or bone marrow using standard tests. In some cases, more precise tests (called measurable residual disease [MRD] tests) can still find a small number of leukemia cells left in the body after treatment. Erik and Charles highlight that reaching remission is an important milestone for patients and their loved ones. However, regular check-ups and monitoring are important to look for any signs of AML returning.
Thank you to our official financial supporter, Thermo Fisher Scientific. All content is developed independently by SES in collaboration with an expert ambassador group; supporters are allowed no influence on our resources.
